HomeCompareGSGTF vs CL

GSGTF vs CL: Dividend Comparison 2026

GSGTF yields 1052.08% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GSGTF wins by $29376466.51M in total portfolio value
10 years
GSGTF
GSGTF
● Live price
1052.08%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29376466.55M
Annual income
$24,748,961,707,406.69
Full GSGTF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — GSGTF vs CL

📍 GSGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGSGTFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GSGTF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GSGTF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSGTF
Annual income on $10K today (after 15% tax)
$89,426.62/yr
After 10yr DRIP, annual income (after tax)
$21,036,617,451,295.69/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, GSGTF beats the other by $21,036,617,446,704.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSGTF + CL for your $10,000?

GSGTF: 50%CL: 50%
100% CL50/50100% GSGTF
Portfolio after 10yr
$14688233.29M
Annual income
$12,374,480,856,404.33/yr
Blended yield
84.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

GSGTF
No analyst data
Altman Z
-9.7
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSGTF buys
0
CL buys
0
No recent congressional trades found for GSGTF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGSGTFCL
Forward yield1052.08%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$29376466.55M$40.8K
Annual income after 10y$24,748,961,707,406.69$5,401.96
Total dividends collected$29025351.72M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GSGTF vs CL ($10,000, DRIP)

YearGSGTF PortfolioGSGTF Income/yrCL PortfolioCL Income/yrGap
1← crossover$115,908$105,207.79$11,012$312.01+$104.9KGSGTF
2$1,263,685$1,139,663.68$12,196$412.95+$1.25MGSGTF
3$12,964,467$11,612,324.37$13,599$549.66+$12.95MGSGTF
4$125,211,982$111,340,001.64$15,288$736.64+$125.20MGSGTF
5$1,138,959,685$1,004,982,865.01$17,353$995.28+$1138.94MGSGTF
6$9,762,216,739$8,543,529,875.74$19,926$1,357.80+$9762.20MGSGTF
7$78,882,996,544$68,437,424,632.64$23,194$1,873.82+$78882.97MGSGTF
8$601,231,379,017$516,826,572,714.96$27,439$2,621.52+$601231.35MGSGTF
9$4,324,770,879,470$3,681,453,303,922.24$33,088$3,727.38+$4324770.85MGSGTF
10$29,376,466,548,439$24,748,961,707,406.69$40,806$5,401.96+$29376466.51MGSGTF

GSGTF vs CL: Complete Analysis 2026

GSGTFStock

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

Full GSGTF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this GSGTF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSGTF vs SCHDGSGTF vs JEPIGSGTF vs OGSGTF vs KOGSGTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.